-
公开(公告)号:US06673808B1
公开(公告)日:2004-01-06
申请号:US09673260
申请日:2000-11-22
申请人: Rinta Ibuki , Fumio Shimojo , Satoshi Ueda , Toshihiko Toyoda , Masayuki Yamanaka , Erika Yoshida
发明人: Rinta Ibuki , Fumio Shimojo , Satoshi Ueda , Toshihiko Toyoda , Masayuki Yamanaka , Erika Yoshida
IPC分类号: A61K3144
CPC分类号: A61K9/0014 , A61K31/40 , A61K31/436 , A61K47/08 , A61K47/14 , A61K47/32 , A61K47/38 , C07D498/04 , Y10S514/947
摘要: To provide a pharmaceutical composition comprising a macrolide compound, such as tricyclic compound (I) or its pharmaceutically acceptable salt, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener. It is satisfactory in stability and absorption kinetics and/or a low irritation potential.
摘要翻译: 提供包含大环内酯化合物如三环化合物(I)或其药学上可接受的盐,溶解/吸收促进剂,药物基质和任选的相容剂和/或增稠剂的药物组合物。 其稳定性和吸收动力学和/或低刺激潜力令人满意。
-
公开(公告)号:US06586444B2
公开(公告)日:2003-07-01
申请号:US10005645
申请日:2001-12-07
申请人: Rinta Ibuki , Fumio Shimojo , Satoshi Ueda , Toshihiko Toyoda , Masayuki Yamanaka , Erika Yoshida
发明人: Rinta Ibuki , Fumio Shimojo , Satoshi Ueda , Toshihiko Toyoda , Masayuki Yamanaka , Erika Yoshida
IPC分类号: A61K3144
CPC分类号: A61K9/0014 , A61K31/40 , A61K31/436 , A61K47/08 , A61K47/14 , A61K47/32 , A61K47/38 , C07D498/04 , Y10S514/947
摘要: To provide a pharmaceutical composition comprising a macrolide compound, such as tricyclic compound (I) or its pharmaceutically acceptable salt, a dissolution/absorption promoter, a pharmaceutical base, and optionally a compatibilizing agent and/or a thickener. It is satisfactory in stability and absorption kinetics and/or a low irritation potential.
-
公开(公告)号:US06387918B1
公开(公告)日:2002-05-14
申请号:US09367698
申请日:1999-08-20
申请人: Masayuki Yamanaka , Fumio Shimojo , Satoshi Ueda , Toshihiko Toyoda , Rinta Ibuki , Norio Ohnishi
发明人: Masayuki Yamanaka , Fumio Shimojo , Satoshi Ueda , Toshihiko Toyoda , Rinta Ibuki , Norio Ohnishi
IPC分类号: A61K3144
CPC分类号: A61K9/0014 , A61K31/407 , A61K31/436 , A61K47/10 , A61K47/14 , A61K47/32
摘要: A pharmaceutical composition comprising a tricyclic compound (I) or its pharmaceutically acceptable salt, an oil substance, a surfactant, a hydrophilic substance, water, and optionally a pH control agent, with enhanced stability, absorbability and/or a low irritation potential, is provided.
摘要翻译: 具有增强的稳定性,吸收性和/或低刺激潜力的三环化合物(I)或其药学上可接受的盐,油性物质,表面活性剂,亲水性物质,水和任选的pH控制剂的药物组合物是 提供。
-
-